Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.
Saved in:
| Title: | Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. |
|---|---|
| Authors: | Cass SH; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Tobin JWD; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Seo YD; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Gener-Ricos G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Keung EZ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Burton EM; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., McQuade JL; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lazar AJ; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Mason R; Gold Coast University Hospital, Southport., Millward M; University of Western Australia, Perth., Sandhu S; Peter Macallum Cancer Centre, Melbourne., Khoo C; Peter Macallum Cancer Centre, Melbourne., Warburton L; Fiona Stanley Hospital, Perth; Edith Cowan University, Joondalup; Future Health Research and Innovation Fund/Raine Clinician Research Fellowship., Guerra V; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston., Haydon A; Alfred Hospital, Melbourne., Dearden H; Melanoma Institute Australia, The University of Sydney, Sydney., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney; Westmead Hospital, Sydney, Australia., Smith JL; Westmead Hospital, Sydney, Australia., Mollee P; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Burgess M; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Mapp S; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Keane C; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Atkinson V; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia., Parikh SA; Mayo Clinic, Rochester, USA., Markovic SN; Mayo Clinic, Rochester, USA., Ding W; Mayo Clinic, Rochester, USA., Call TG; Mayo Clinic, Rochester, USA., Hampel PJ; Mayo Clinic, Rochester, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney., Wargo JA; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwargo@mdanderson.org., Ferrajoli A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Sep; Vol. 34 (9), pp. 796-805. Date of Electronic Publication: 2023 Jul 04. |
| Publication Type: | Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37414216 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cass+SH%22">Cass SH</searchLink>; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Tobin+JWD%22">Tobin JWD</searchLink>; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Seo+YD%22">Seo YD</searchLink>; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Gener-Ricos+G%22">Gener-Ricos G</searchLink>; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Keung+EZ%22">Keung EZ</searchLink>; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Burton+EM%22">Burton EM</searchLink>; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Davies+MA%22">Davies MA</searchLink>; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22McQuade+JL%22">McQuade JL</searchLink>; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Departments of Pathology and Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Mason+R%22">Mason R</searchLink>; Gold Coast University Hospital, Southport.<br /><searchLink fieldCode="AU" term="%22Millward+M%22">Millward M</searchLink>; University of Western Australia, Perth.<br /><searchLink fieldCode="AU" term="%22Sandhu+S%22">Sandhu S</searchLink>; Peter Macallum Cancer Centre, Melbourne.<br /><searchLink fieldCode="AU" term="%22Khoo+C%22">Khoo C</searchLink>; Peter Macallum Cancer Centre, Melbourne.<br /><searchLink fieldCode="AU" term="%22Warburton+L%22">Warburton L</searchLink>; Fiona Stanley Hospital, Perth; Edith Cowan University, Joondalup; Future Health Research and Innovation Fund/Raine Clinician Research Fellowship.<br /><searchLink fieldCode="AU" term="%22Guerra+V%22">Guerra V</searchLink>; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Haydon+A%22">Haydon A</searchLink>; Alfred Hospital, Melbourne.<br /><searchLink fieldCode="AU" term="%22Dearden+H%22">Dearden H</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney.<br /><searchLink fieldCode="AU" term="%22Carlino+MS%22">Carlino MS</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney; Westmead Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+JL%22">Smith JL</searchLink>; Westmead Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Mollee+P%22">Mollee P</searchLink>; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Burgess+M%22">Burgess M</searchLink>; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Mapp+S%22">Mapp S</searchLink>; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Keane+C%22">Keane C</searchLink>; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Atkinson+V%22">Atkinson V</searchLink>; Haematology Department, Princess Alexandra Hospital, Woolloongabba; University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Parikh+SA%22">Parikh SA</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Markovic+SN%22">Markovic SN</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Ding+W%22">Ding W</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Call+TG%22">Call TG</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Hampel+PJ%22">Hampel PJ</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney; Faculty of Medicine and Health, The University of Sydney, Sydney; The University of Sydney Charles Perkins Centre, Sydney; The University of Sydney Royal North Shore and Mater Hospitals, Sydney.<br /><searchLink fieldCode="AU" term="%22Wargo+JA%22">Wargo JA</searchLink>; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwargo@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Ferrajoli+A%22">Ferrajoli A</searchLink>; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2023 Sep; Vol. 34 (9), pp. 796-805. <i>Date of Electronic Publication: </i>2023 Jul 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37414216 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.06.007 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 796 Titles: – TitleFull: Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cass SH – PersonEntity: Name: NameFull: Tobin JWD – PersonEntity: Name: NameFull: Seo YD – PersonEntity: Name: NameFull: Gener-Ricos G – PersonEntity: Name: NameFull: Keung EZ – PersonEntity: Name: NameFull: Burton EM – PersonEntity: Name: NameFull: Davies MA – PersonEntity: Name: NameFull: McQuade JL – PersonEntity: Name: NameFull: Lazar AJ – PersonEntity: Name: NameFull: Mason R – PersonEntity: Name: NameFull: Millward M – PersonEntity: Name: NameFull: Sandhu S – PersonEntity: Name: NameFull: Khoo C – PersonEntity: Name: NameFull: Warburton L – PersonEntity: Name: NameFull: Guerra V – PersonEntity: Name: NameFull: Haydon A – PersonEntity: Name: NameFull: Dearden H – PersonEntity: Name: NameFull: Menzies AM – PersonEntity: Name: NameFull: Carlino MS – PersonEntity: Name: NameFull: Smith JL – PersonEntity: Name: NameFull: Mollee P – PersonEntity: Name: NameFull: Burgess M – PersonEntity: Name: NameFull: Mapp S – PersonEntity: Name: NameFull: Keane C – PersonEntity: Name: NameFull: Atkinson V – PersonEntity: Name: NameFull: Parikh SA – PersonEntity: Name: NameFull: Markovic SN – PersonEntity: Name: NameFull: Ding W – PersonEntity: Name: NameFull: Call TG – PersonEntity: Name: NameFull: Hampel PJ – PersonEntity: Name: NameFull: Long GV – PersonEntity: Name: NameFull: Wargo JA – PersonEntity: Name: NameFull: Ferrajoli A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1569-8041 Numbering: – Type: volume Value: 34 – Type: issue Value: 9 Titles: – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology Type: main |
| ResultId | 1 |